Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    Registration is now open until January 15, 2027, at 5 p.m. ET, replacing the notice that registration would open November 2, 2026. A direct registration link has also been added.

    Clinical Trials to Validate AI-Driven Drug Repurposing 2026

    Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.

    Cures Within ReachForecasted Jun 26, 2027$100,000Forecasted

    Real-World Evidence Innovation Challenge

    Real-World Evidence Innovation Challenge supports individuals, teams, and entities validating clinical data analytic methods to establish reliable, reproducible performance across health systems.

    NIH ChallengesDue Feb 2, 2027$1,050,000

    Research on Complex Generics

    FDA funds research on complex generics to expand access to safe, effective generic medicines and reduce drug shortages through a more competitive, multi-sourced U.S. market.

    HHS-FDADue Dec 14, 2026$12,000,000Newly Listed

    Center for Research on Complex Generics (U18) Clinical Trials Optional

    FDA grant to fund a center researching complex generics, fostering collaboration between the FDA, industry, academia, and the public to improve access to generic drugs.

    HHS-FDA$1,500,000Forecasted

    NIH Complement Animal Research in Experimentation NAMs Reduction to Practice Challenge

    NIH Complement Animal Research in Experimentation NAMs Reduction to Practice Challenge supports teams developing human-based testing platforms to improve predictions of human responses and complement animal models.

    NIH ChallengesDue Mar 22, 2027$1,430,000